BIM

115.5

+1.49%↑

SRT3

228.3

-0.7%↓

GXI

55.3

+2.88%↑

ICAD

21.08

-0.57%↓

BIM

115.5

+1.49%↑

SRT3

228.3

-0.7%↓

GXI

55.3

+2.88%↑

ICAD

21.08

-0.57%↓

BIM

115.5

+1.49%↑

SRT3

228.3

-0.7%↓

GXI

55.3

+2.88%↑

ICAD

21.08

-0.57%↓

BIM

115.5

+1.49%↑

SRT3

228.3

-0.7%↓

GXI

55.3

+2.88%↑

ICAD

21.08

-0.57%↓

BIM

115.5

+1.49%↑

SRT3

228.3

-0.7%↓

GXI

55.3

+2.88%↑

ICAD

21.08

-0.57%↓

Search

EssilorLuxottica SA

Open

BrancheGesundheitswesen

252.2 0.24

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

251.3

Max

255.1

Schlüsselkennzahlen

By Trading Economics

Einkommen

-371M

994M

Verkäufe

-72M

13B

KGV

Branchendurchschnitt

48.301

57.333

EPS

2.976

Dividendenrendite

1.6

Gewinnspanne

7.52

Angestellte

153,498

EBITDA

635M

3.6B

Empfehlungen

By TipRanks

Empfehlungen

Buy

12-Monats-Prognose

+12.78% upside

Dividenden

By Dow Jones

Dividendenrendite

Branchendurchschnitt

1.60%

2.63%

Nächstes Ergebnis

24. Juli 2025

Marktstatistiken

By TradingEconomics

Marktkapitalisierung

-8.6B

113B

Vorheriger Eröffnungskurs

251.96

Vorheriger Schlusskurs

252.2

Technischer Score

By Trading Central

Vertrauen

Strong Bullish Evidence

EssilorLuxottica SA Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

23. Apr. 2025, 18:17 UTC

Ergebnisse

Ray-Ban Maker EssilorLuxottica Implements Measures to Weather U.S. Tariffs -- Update

23. Apr. 2025, 16:36 UTC

Ergebnisse

Ray-Ban Maker EssilorLuxottica to Implement Measures to Mitigate U.S. Tariffs

12. Feb. 2025, 18:35 UTC

Ergebnisse

Ray-Ban Maker EssilorLuxottica Logs Higher Sales Amid North America, China Growth -- Update

12. Feb. 2025, 17:32 UTC

Ergebnisse

Ray-Ban Maker EssilorLuxottica Posts Higher Profit on Sales Growth

2. Jan. 2025, 17:29 UTC

Akquisitionen, Fusionen, Übernahmen

EssilorLuxottica Buys AI Startup in Hearing Market Push

24. Apr. 2025, 09:58 UTC

Market Talk
Ergebnisse

EssilorLuxottica's Main Challenge Is Trade Environment -- Market Talk

24. Apr. 2025, 09:35 UTC

Market Talk
Ergebnisse

EssilorLuxottica's Results Show Resilience Given Macroeconomic Woes -- Market Talk

24. Apr. 2025, 08:11 UTC

Market Talk
Ergebnisse

EssilorLuxottica Shows Resilience, But Market Might Turn Cautious -- Market Talk

3. Apr. 2025, 08:00 UTC

Market Talk

European Luxury Companies Fall After Tariffs; Profit Margins Expected to Shrink -- Market Talk

28. März 2025, 08:57 UTC

Market Talk

EssilorLuxottica Should Be Able to Cope With U.S. Volatility -- Market Talk

13. Feb. 2025, 11:05 UTC

Market Talk
Ergebnisse

EssilorLuxottica Seems Poised to Ride the Technology Wave -- Market Talk

13. Feb. 2025, 10:54 UTC

Market Talk
Ergebnisse

EssilorLuxottica's Midterm Margin Target Seems Challenging -- Market Talk

13. Feb. 2025, 08:41 UTC

Market Talk
Ergebnisse

EssilorLuxottica's Sales Are Better Than Expected -- Market Talk

12. Feb. 2025, 17:05 UTC

Ergebnisse

EssilorLuxottica Backs Mid-Term Targets

12. Feb. 2025, 17:05 UTC

Ergebnisse

EssilorLuxottica 2024 Oper Pft EUR3.45B

12. Feb. 2025, 17:04 UTC

Ergebnisse

Analysts Had Seen EssilorLuxottica 2024 Net Pft at EUR2.50B

12. Feb. 2025, 17:04 UTC

Ergebnisse

EssilorLuxottica 2024 Net Pft EUR2.36B

12. Feb. 2025, 17:03 UTC

Ergebnisse

EssilorLuxottica 2024 Rev EUR26.51B

12. Feb. 2025, 17:03 UTC

Ergebnisse

EssilorLuxottica 4Q Rev EUR6.78B

12. Feb. 2025, 17:01 UTC

Ergebnisse

Analysts Had Seen EssilorLuxottica 4Q Rev at EUR6.68B

12. Feb. 2025, 17:00 UTC

Ergebnisse

EssilorLuxottica Declares Dividend of EUR3.95 a share

11. Feb. 2025, 16:30 UTC

Market Talk

EssilorLuxottica Has Bright Future Ahead Amid Smart Glasses Push -- Market Talk

11. Feb. 2025, 10:58 UTC

Market Talk
Akquisitionen, Fusionen, Übernahmen

EssilorLuxottica Continues Ophthalmology Expansion With Cellview Acquisition -- Market Talk

11. Feb. 2025, 07:03 UTC

Akquisitionen, Fusionen, Übernahmen

EssilorLuxottica Doesn't Disclose Financial Details

11. Feb. 2025, 07:03 UTC

Akquisitionen, Fusionen, Übernahmen

EssilorLuxottica Aims to Build Wider Portfolio of Ophthalmic Instruments, Services With Deal

11. Feb. 2025, 07:02 UTC

Akquisitionen, Fusionen, Übernahmen

EssilorLuxottica: Toronto-Based Cellview Specializes in Diagnostic via Retinal Imaging

11. Feb. 2025, 07:01 UTC

Akquisitionen, Fusionen, Übernahmen

EssilorLuxottic Acquires Canadian Med-Tech Startup Cellview

11. Feb. 2025, 07:00 UTC

Akquisitionen, Fusionen, Übernahmen

EssilorLuxottica to Buy Cellview

2. Jan. 2025, 17:04 UTC

Akquisitionen, Fusionen, Übernahmen

EssilorLuxottica Didn't Disclose Financial Details

2. Jan. 2025, 17:03 UTC

Akquisitionen, Fusionen, Übernahmen

EssilorLuxottica: This Allows People With Hearing Impairment to Better Understand Speech

Peer-Vergleich

Kursveränderung

EssilorLuxottica SA Prognose

Kursziel

By TipRanks

12.78% Vorteil

12-Monats-Prognose

Durchschnitt 284.2 EUR  12.78%

Hoch 335 EUR

Tief 245 EUR

Basierend auf 11 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für EssilorLuxottica SA – Dist angeboten haben.

Rating-Konsens

By TipRanks

Buy

11 ratings

7

Buy

4

Halten

0

Sell

Technischer Score

By Trading Central

246.5 / 253.2Unterstützung & Widerstand

Kurzfristig

Strong Bullish Evidence

Mittelfristig

Very Strong Bearish Evidence

Langfristig

No Evidence

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

$

Über EssilorLuxottica SA

EssilorLuxottica Société anonyme designs, manufactures, and distributes ophthalmic lenses, frames, and sunglasses in Europe, the Middle East, Africa, Latin America, the Asia-Pacific, and North America. It operates through Professional Solutions and Direct to Consumer segments. The company offers lens under the Essilor, Varilux, Crizal, Eyezen, Stellest, Xperio, Transitions, Ray-Ban, Oakley, Barberini, KODAK Lens, Nikon, Shamir, eyexpert, iWear, Humanware, and Optifog brands. It also provides finishing equipment, vision performance screening, eye examination and refractions, fitting parameter measurements, and small tools and consumables under the Essilor Instruments brand; high-tech equipment for optical surfacing, polishing, measuring, coating, and finishing, as well as consumables, tools, and services under the Satisloh brand. In addition, the company provides eyewear products under the Ray-Ban, Oakley, Persol, Oliver Peoples, Vogue Eyewear, Arnette, Alain Mikli, Costa, Bliz, Native, Luxottica, Sferoflex, Bolon, Molsion, DbyD, and Unofficial and Seen, as well as other Licensed brands. In addition, the company designs, develops, markets, and maintains lens edging and mounting instruments for opticians and prescription laboratories; and optometry instruments for eyecare professionals, schools, occupational medicine centers, military, and other institutions. It wholesales its products to independent opticians, distributors, third-party e-commerce platforms, and large retail chains in the eyecare and eyewear industry; and sells directly to consumers through the network of brick and mortar retail network and its online channels. The company was formerly known as Essilor International Société Anonyme and changed its name to EssilorLuxottica Société anonyme in October 2018. EssilorLuxottica Société anonyme was founded in 1849 and is headquartered in Paris, France.